Mona El‐Gamil

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins, Richard A. Morgan, Steven A. Feldman et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

Life Sciences, Immunology, Oncology +17

Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines

Bonnee Rubinfeld, Paul F. Robbins, Mona El‐Gamil et al. · Science · 1997 · 1.2K citations

Life Sciences, Genetics, Molecular Biology +17

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Paul F. Robbins, Yong‐Chen Lu, Mona El‐Gamil et al. · Nature Medicine · 2013 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +16

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran et al. · Clinical Cancer Research · 2014 · 801 citations · Full text

Medicine, Immunology, Oncology +17

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Paul F. Robbins, Mona El‐Gamil, Yongfeng Li et al. · The Journal of Experimental Medicine · 1996 · 548 citations · Full text

Life Sciences, Immunology, Oncology +17